2021-May-15 10:55
2021-May-1  19:18

Official: No Side-Effects Reported in COV-Iran Coronavirus Vaccine

TEHRAN (FNA)- Senior member of Iran’s National Task Force for Fighting COVID-19 Minou Mohraz said on Saturday that the coronavirus vaccine, COV-Iran, which has been developed by the Iranian scientists at the Headquarters for Executing the Order of Imam Khomeini (HEIKO) has shown no side effects.

“Fortunately, I have had no side effects to date. Meantime, 330 volunteers who have received the vaccine have not had any side effects either so far,” said Mohraz, who has earlier received the COV-Iran vaccine.

“The vaccine is effective against the British virus, but we are still not sure if it is effective against the Coronavirus mutations in South Africa and India,” she added.

Mohraz, also a senior member of the team to assess the efficiency of the Iran-made vaccine, said that nearly 30 million doses of the vaccine will be delivered by the HEIKO to the health ministry by mid Summer.

Head of HEIKO’s information office Hojjat Niki Maleki tweeted on Friday that the efforts of the Iranian scientists have yielded fruit and within a couple of weeks the country will produce some 1 million doses of COV-Iran Barekat vaccine.

He added that another 3 million doses are expected to be produced by June 20.

In relevant remarks last week, Head of HEIKO Mohammad Mokhber said that nearly 30 million doses of COV-Iran Barekat vaccine will be produced and delivered to the health ministry.

“One million doses of the vaccine will be produced this month, 3 million doses next month, 10 to 12 million doses in July, and 13 to 15 million doses in August,” Mokhber said last Sunday, adding that the vaccines would be given to the Health Ministry for vaccination.

He noted that from September, 20 million doses of the vaccine would be produced monthly.

The official pointed out that people's concerns regarding the virus would be resolved within the next 3 to 4 months.

He concluded that all Iranian vaccines had achieved the human testing phase and desirable results, but COV-Iran Barekat has had fewer side effects.